Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
240 patients around the world
Available in Mexico, United States, Spain
The overall purpose of this two-part study is to evaluate the efficacy, safety and
tolerability of iptacopan (LNP023) in addition to standard of care treatment.
